Select Medical Holdings Corporation (SEM)
ROE
Obliczenia
|
2023/Q4 (31 gru 2023) |
2023/Q3 (30 wrz 2023) |
2023/Q2 (30 cze 2023) |
2023/Q1 (31 mar 2023) |
2022/Q4 (31 gru 2022) |
2022/Q3 (30 wrz 2022) |
2022/Q2 (30 cze 2022) |
2022/Q1 (31 mar 2022) |
||
|---|---|---|---|---|---|---|---|---|---|
| Zysk netto (ttm) | w tys. USD | 234 718 | 216 500 | 196 216 | 174 143 | 153 385 | 175 165 | 223 369 | 329 416 |
| Kapitał własny | w tys. USD | 1 288 300 | 1 267 810 | 1 246 040 | 1 170 450 | 1 121 920 | 1 105 600 | 1 071 410 | 1 138 140 |
| ROE | 18,22% | 17,08% | 15,75% | 14,88% | 13,67% | 15,84% | 20,85% | 28,94% |
2023/Q4 obliczenia
ROE = Zysk netto (ttm) ÷ Kapitał własny
= $234 718K ÷ $1 288 300K
= 18,22%
Analiza porównawcza
2023/Q4
Nazwa spółki
Symbol
ROE
Select Medical Holdings Corporation
SEM
18,22%
Acadia Healthcare Company Inc
ACHC
-0,78%
Encompass Health Corp
EHC
21,22%
Ensign Group Inc
ENSG
14,04%
HCA Healthcare Inc
HCA
—
National Healthcare Corp.
NHC
7,35%
Pediatrix Medical Group Inc
MD
-7,11%
Tenet Healthcare Corp.
THC
38,00%
Universal Health Services, Inc.
UHS
11,67%